Low insulin-like growth factor-1 levels are associated with anaemia in adult non-diabetic subjects

Thrombosis and Haemostasis

Volumn 105, Issue 2, 2011, Pages 365-370

  Succurro, Elena ^a   Arturi, Franco ^a   Caruso, Vittoria ^a   Rudi, Stefania ^a   Sciacqua, Angela ^a   Andreozzi, Francesco ^a   Hribal, Marta L ^a   Perticone, Francesco ^a   Sesti, Giorgio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Anaemia; Cardiovascular risk; IGF 1; Inflammation

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; IRON; SOMATOMEDIN C;

ADULT; ANEMIA; ARTICLE; DISEASE ASSOCIATION; DRUG USE; FEMALE; GENDER; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; ANEMIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DOWN-REGULATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEMOGLOBINS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; ITALY; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 79851473024     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-06-0379     Document Type: Article

References (30)

1. Kosiborod M, Smith GL, Radford MJ, et al. The prognostic importance of anemia in patients with heart failure. Am J Med 2003; 114: 112-119. (Pubitemid 36183592)
2. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 2003; 107: 223-225. (Pubitemid 36135214)
3. Anand I, McMurray JJ, Whitmore J, et al. Anemia and its relationship to clinical outcome in heart failure. Circulation 2004; 110: 149-154. (Pubitemid 38924582)
4. Foley RN, Parfrey PS, Harnett JD, et al. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 1996; 28: 53-61. (Pubitemid 26231466)
5. Keith DS, Nichols GA, Gullion CM, et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164: 659-663. (Pubitemid 38392981)
6. Thomas MC, MacIsaac RJ, Tsalamandris C, et al. The burden of anaemia in type 2 diabetes and the role of nephropathy: A cross-sectional audit. Nephrol Dial Transplant 2004; 19: 1792-1797. (Pubitemid 38961389)
7. Tong PC, Kong AP, So WY, et al. Hematocrit, independent of chronic kidney disease, predicts adverse cardiovascular outcomes in Chinese patients with type 2 diabetes. Diabetes Care 2006; 29: 2439-2444. (Pubitemid 44912249)
8. Beghe C, Wilson A, Ershler WB. Prevalence and outcomes of anemia in geriatrics: a systematic review of the literature. Am J Med 2004; 116: 3S-10S.
9. Zakai NA, Katz R, Hirsch C, et al. A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch Intern Med 2005; 165: 2214-2220. (Pubitemid 41549915)
10. Sarnak MJ, Tighiouart H, Manjunath G, et al. Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol 2002; 40: 27-33. (Pubitemid 34701373)
11. Claustres M, Chatelain P, Sultan C. Insulin-like growth factor I stimulates human erythroid colony formation in vitro. J Clin Endocrinol Metab 1987; 65: 78-82. (Pubitemid 17092091)
12. Correa PN, Axelrad AA. Production of erythropoietic bursts by progenitor cells from adult human peripheral blood in an improved serum-free medium: role of insulin-like growth factor 1. Blood 1991; 78: 2823-2833.
13. Merchav S, Tatarsky I, Hochberg Z. Enhancement of erythropoiesis in vitro by human growth hormone is mediated by insulin-like growth factor I. Br J Haematol 1988; 70: 267-271. (Pubitemid 18265242)
14. Powell DR, Rosenfeld RG, Baker BK, et al. Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor-I (IGF-I) and IGF-II in acid-chromatographed uremic serum. J Clin Endocrinol Metab 1986; 63: 1186-1192. (Pubitemid 17173059)
15. Christ ER, Cummings MH, Westwood NB, et al. The importance of growth hormone in the regulation of erythropoiesis, red cell mass, and plasma volume in adults with growth hormone deficiency. J Clin Endocrinol Metabol 1997; 82: 2985-2990. (Pubitemid 27385660)
16. Nilsson-Ehle H, Bengtsson BA, Lindstedt G, et al. Insulin-like growth factor-1 is a predictor of blood haemoglobin concentration in 70-yr-old subjects. Eur J Haematol 2005; 74: 111-116. (Pubitemid 40175313)
17. Chu LW, Lam KS, Tam SC, et al. A randomized controlled trial of low-dose recombinant human growth hormone in the treatment of malnourished elderly medical patients. J Clin Endocrinol Metab 2001; 86: 1913-1920. (Pubitemid 32472897)
18. Succurro E, Andreozzi F, Sciaqua A, et al. Reciprocal association of plasma IGF-1 and interleukin-6 levels with cardiometabolic risk factors in nondiabetic subjects. Diabetes Care 2008; 31: 1886-1888.
19. Succurro E, Marini MA, Arturi F, et al.. Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis. Atherosclerosis 2009; 207: 245-249.
20. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266.
21. World Health Organization. Nutritional anaemias: report of a WHO scientific group. World Health Organ Tech Rep Ser 1968; 405: 3-37.
22. Jiménez D, Escobar C, Martí D, et al. Association of anaemia and mortality in patients with acute pulmonary embolism. Thromb Haemost 2009; 102: 153-158.
23. Auernhammer CJ, Strasburger CJ. Effects of growth hormone and insulin-like growth factor I on the immune system Eur J Endocrinol 1995; 133: 635-645.
24. Sukhanov S, Higashi Y, Shai SY, et al. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2007; 27: 2684-2690. (Pubitemid 350158923)
25. Means RT Jr , Krantz SB. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992; 80: 1639-1647.
26. Bhatia V, Chaudhuri A, Tomar R, et al. Low testosterone and high C-reactive protein concentrations predict low hematocrit in type 2 diabetes. Diabetes Care 2006; 29: 2289-2294. (Pubitemid 44899867)
27. Dallman PR, Yip R, Johnson C. Prevalence and causes of anemia in the United States, 1976 to 1980. Am J Clin Nut 1984; 39: 437-445.
28. Meyers LD, Habicht JP, Johnson CL , et al. Prevalence of anemia and iron deficiency anemia in black and white women in the United States estimated by two methods. Am J Public Health 1983; 73: 1042-1049. (Pubitemid 13037733)
29. Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood 2006; 107: 1747-1750.
30. Kaaks R, Toniolo P, Akhmedkhanov A, et al. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000; 92: 1592-1600.